ProfileGDS4177 / 220122_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 75% 68% 31% 36% 35% 53% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated144.1375
GSM603099KU-812 non-treated87.7468
GSM603098KCL-22 Imatinib-treated14.7631
GSM603097KCL-22 non-treated17.836
GSM603102JURL-MK1 Imatinib-treated18.1635
GSM603101JURL-MK1 non-treated37.2553